What are the American Thoracic Society (ATS) recommendations for treatment of Mycobacterium avium complex (MAC) in bronchiectasis?

Updated: Sep 15, 2020
  • Author: Ethan E Emmons, MD; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
  • Print
Answer

American Thoracic Society recommendations for treatment of Mycobacterium avium complex (MAC) infection in the setting of bronchiectasis are as follows:

  • Combination therapy with clarithromycin, rifampin, ethambutol

  • Consider streptomycin as a possible fourth drug

  • Continue therapy until the patient's culture results have been negative for 1 year

  • The typical duration of therapy is 18-24 months


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!